Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,760.00    90.00 (2.45%)
Bid:
3,744.00
Ask:
3,748.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Directorate Change

18 Oct 2024 07:00

RNS Number : 6755I
4imprint Group PLC
18 October 2024
 

 

 18 October 2024

 

4imprint Group plc

 

CFO Designate Appointment

 

 

4imprint Group plc ("4imprint" or the "Company") today announces the appointment of Michelle Brukwicki as CFO Designate effective 9 December 2024. This follows the announcement on 22 May 2024 that David Seekings had informed the Company of his intention to retire from the Board and from his role as CFO before the end of 2025. David's six month notice period will commence from December 31st. 

 

The appointment follows a thorough and rigorous recruitment and selection process led by the Nomination Committee of the Board. 

 

Michelle is a Certified Public Accountant in the US with accounting experience gained initially with Deloitte & Touche and is presently Senior Vice President - Finance and Chief Financial Officer of TDS Telecom, a division of Telephone and Data Systems, Inc (TDS). Michelle brings over 25 years of financial and accounting related experience at publicly listed companies, along with extensive experience in strategic planning and business development, leadership development, enterprise risk management and investor relations. 

 

Michelle will initially be appointed as CFO Designate and then is expected to become CFO and be appointed to the Board no later than May 31, 2025. A further announcement will be made in due course. 

 

Paul Moody, Chair, commented: "Michelle brings a wealth of relevant technical experience to the company, as well as proven evidence of strategic thought. As importantly, Michelle's approach to the leadership and development of people, together with her personal values make her a perfect fit with our company's culture. I am looking forward to working with Michelle."

 

Kevin Lyons-Tarr, CEO, commented: "I am delighted to welcome Michelle to 4imprint. Her extensive experience, leadership style and strategic mindset will undoubtedly be an invaluable addition to our team as we work together to drive the business forward."

 

Michelle Brukwicki, CFO Designate, commented: "It is an honour to join 4imprint as the next CFO. The Company's purpose, operations and culture are very impressive. I look forward to collaborating with the Board, the management team, and associates across the organization to build on 4imprint's strong foundation."

 

 

Notes: 

1. There is no further information in respect of Michelle Brukwicki which would require disclosure under Listing Rule 6.4.6. 

2. Michelle Brukwicki's remuneration arrangements have been set in accordance with the Directors' Remuneration Policy approved by shareholders, including an annual salary of $470,000pa, an entitlement to an annual bonus opportunity of up to 150% and an invitation to join the new 4imprint LTIP starting in 2025.

 

 

For further information, please contact:

 

4imprint Group plc

Tel. + 44 (0) 20 3709 9680

Email: hq@4imprint.co.uk

MHP Group

Tel. + 44 (0) 7884 494112

Email: 4imprint@mhpgroup.com

 

Kevin Lyons-Tarr

Chief Executive Officer

 

Emma Taylor

Company Secretary

Katie Hunt

 

 

Eleni Menikou

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABRBDGBGBDGSR
Date   Source Headline
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase
2nd Sep 20249:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.